Heather Du

  • Biography
  • Key Cases

Heather Du specializes in antitrust and class action litigation. She has more than 10 years of e-discovery experience that focuses on complex discovery and document review projects using a variety of e-discovery technologies. She also assists in other aspects of litigation, including legal research, interview/deposition preparation, and other analytical assignments to support the Firm in providing the best representation to the clients.

Before joining the Firm, Heather was a contract attorney/document reviewer at several San Francisco top tier law firms, where she reviewed documents in securities, patent litigation, class action, civil investigation, and other related practice areas.

Previously, Heather served as a volunteer attorney for the Volunteer Homeless Advocacy Project (“HAP”), where she provided limited scope representation at court-mandated settlement conferences and assisted with trial preparation. She assisted individuals and families at the Volunteer Legal Service Program of the Bar Association of San Francisco. She was a law clerk for the Asian Pacific Islander Legal Outreach and performed a clinical internship for the San Francisco-based Eviction Defense Collaborative. She also interned at the San Francisco based Court House Project and HAP.

Heather is a member of the American Bar Association and the Bar Association of San Francisco.

  • Capacitors Price-Fixing Antitrust Litigation: The Firm is Sole Lead Counsel in a class-action lawsuit alleging that global capacitor manufacturers conspired to fix prices, forcing direct purchasers to pay more. The class is certified and trial is proceeding in 2020. Initial settlements in the case total $343.5 million;
  • In re EpiPen Marketing, Sales Practices, and Antitrust Litigation: The Firm is on the Plaintiffs’ Steering Committee leading a class action alleging that Pfizer and Mylan—manufacturer and distributor of the epinephrine autoinjector EpiPen, respectively—have unlawfully created and abused a monopoly for the life-saving product. Plaintiffs seek recovery of damages and overpayments from at least 2009 through the present, as well as injunctive relief under the federal antitrust laws and various state consumer protection and antitrust laws;
  • Generic Drug Price-Fixing Antitrust Litigation: The Firm is on the Plaintiffs’ Steering Committee representing U.S. consumers and insurers in a multi-district antitrust litigation accusing several generic drug manufacturers with conspiring to fix and raise prices for 18 generic medications. In the past few years, prices for these drugs have skyrocketed by more than 1,000 percent. Consumers blame the companies for engineering these price hikes, eliminating the benefits of competition, and forcing them to pay exorbitant prices. The Firm is also currently investigating many other generic drugs for potential class action claims;
  • Interior Molded Doors Litigation: The Firm is Interim Co-Lead Counsel for a proposed Indirect Purchaser Plaintiffs Class of individuals and companies who purchased interior molded doors from Defendants JELD-WEN, Inc. and Masonite Corporation. Plaintiffs allege that as a result of Defendants’ alleged anticompetitive conduct, Plaintiffs and other potential Class members paid more for doors than they would have in a competitive environment.